Kularatne, Ranmini
Blondeel, Karel http://orcid.org/0000-0001-6900-9124
Kasaro, Margaret
Maseko, Venessa
Bosomprah, Samuel
Silva, Ronaldo
Laverty, Maura
Kurbonov, Firdavs
Mirandola, Massimo
Peeling, Rosanna W
Article History
Received: 18 August 2022
Accepted: 31 May 2024
First Online: 19 June 2024
Declarations
:
: The core protocol upon which this study was based was independently peer reviewed and approved by the Research Project Review Panel (RP2) of the WHO Department of Sexual and Reproductive Health and Research (SRH) and by the WHO Ethics Review Committee (ERC). The protocol has also been adapted to the individual countries and approved by RP2, ERC, and institutional review boards at each site. Details are provided in the published protocol [16].
: Not applicable.
: The POCT manufacturers disclosed and furnished free of charge to WHO the information and sufficient quantities of the products in order to enable this evaluation as part of the WHO/SRH STI POC initiative. WHO is entitled to evaluate and publish the trial results, and to exclusively control this evaluation and the content of the aforesaid publication. WHO submitted the results of the analysis to the manufacturers for review, comments received have been considered in good faith, the decision to publish remained with WHO.